Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RNA | Avidity Biosciences, Inc. | Chief Financial Officer | $2.71M | -$13M | -82.8% | Dec 18, 2024 |
VERV | Verve Therapeutics, Inc. | Director | Jun 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|